News and Announcements
JetPack Aviation Launches First Civilian Flight
- Published March 21, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
It’s something straight out of a James Bond film, the future society that everyone has imagined. Mischa Pollack, a vlogger and designer from Los Angeles, was picked for JetPack Aviation first “civilian” flight. After less than 10 hours of training, he was able to lift off and test the JB-10 pack.
KEY TAKEAWAYS:
- JetPack Aviation has been working on a functional jetpack for well over a decade.
- About two years ago, company CEO David Meyman flew the JB-9 prototype around the Statue of Liberty in a viral video.
- Now that the company has a functional, reliable blueprint for a jet-powered backpack, it’s focusing more on the creation of a parachute safety system.
- To develop it, it’s seeking traditional investors and running a crowdfunding campaign on Start Engine for smaller, individual investments.
The Daily Mail, reported in 2016 that JetPack Aviation might sell an electric version of the JB-10 this year to “well qualified buyers” for around $250,000 (approximately £198,380 or AU$331,200).
Imagine grabbing your briefcase, unplugging and putting on your pack, taking off to work from your sidewalk. You’d be the envy of your office. Of all the offices. Everywhere.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
